Skip to main content
. 2023 Dec 11;14:1325462. doi: 10.3389/fimmu.2023.1325462

Table 2.

Circulating sPD-1 and sPD-L1 levels of study patients according to baseline characteristics.

Characteristic sPD-1 sPD-L1
Median [IQR], pg/ml p Median [IQR], pg/ml p
Age (years) 
 ≥70
 <70
 
185 [142–276]
148 [93–228]
 
<0.01
 
260 [230–318]
234 [184–298]

0.02
Sex 
 Female
 Male
 
166 [119–264]
169 [112–257]
 
0.78
 
235 [190–279]
258 [218–319]

0.02
ECOG performance status 
 ≥2
 0 or 1
 
203 [148–284]
163 [111–246]
0.11  
302 [261–369]
241 [204–300]

0.02
No. of previous regimens 
 ≥2
 0 or 1
 
188 [136–320]
164 [109–235]
 
0.07
 
256 [220–329]
247 [204–302]

0.33

sPD-1, soluble programmed cell death–1; sPD-L1, soluble programmed cell death–ligand 1; IQR, interquartile range.

The p values were determined with the Wilcoxon ranked sum test.